Zobrazeno 1 - 10
of 481
pro vyhledávání: '"Arnaud, Bourdin"'
Autor:
Celia Vidal, Fanny Bertelli, Jean-Pierre Mallet, Raphael Gilson, Jean-Christian Borel, Frédéric Gagnadoux, Arnaud Bourdin, Nicolas Molinari, Dany Jaffuel
Publikováno v:
Respiratory Research, Vol 25, Iss 1, Pp 1-12 (2024)
Abstract Background Over the past three decades, our understanding of sleep apnea in women has advanced, revealing disparities in pathophysiology, diagnosis, and treatment compared to men. However, no real-life study to date has explored the relation
Externí odkaz:
https://doaj.org/article/ea86a1efc966497681887b8b7244ae7f
Autor:
Boris Jung, Maxime Fosset, Matthieu Amalric, Elias Baedorf-Kassis, Brian O’Gara, Todd Sarge, Valerie Moulaire, Vincent Brunot, Arnaud Bourdin, Nicolas Molinari, Stefan Matecki
Publikováno v:
Annals of Intensive Care, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Background The objective was to compare sevoflurane, a volatile sedation agent with potential bronchodilatory properties, with propofol on respiratory mechanics in critically ill patients with COPD exacerbation. Methods Prospective study in
Externí odkaz:
https://doaj.org/article/5d48eb93eaf645f49d2253fab1ddc043
Autor:
Camille Taillé, Marc Humbert, Arnaud Bourdin, Céline Thonnelier, Audrey Lajoinie, Jules Chassetuillier, Mathieu Molimard, Antoine Deschildre
Publikováno v:
ERJ Open Research, Vol 10, Iss 4 (2024)
Externí odkaz:
https://doaj.org/article/2d8cc9ba2a6c417eb8d0b642fc390850
Autor:
Engi Ahmed, Mathieu Fieldès, Chloé Bourguignon, Joffrey Mianné, Aurélie Petit, Nasri Amel, Florent Foisset, Carine Bourdais, Isabelle Vachier, Said Assou, John De Vos, Arnaud Bourdin
Publikováno v:
Stem Cell Research, Vol 77, Iss , Pp 103437- (2024)
Human pluripotent stem cells (hiPSC) represent a unique opportunity to model lung development and chronic bronchial diseases. We generated a hiPSC line from a highly characterized healthy heavy smoker male donor free from emphysema or tobacco related
Externí odkaz:
https://doaj.org/article/dfa2aa4ace45412296f36548570c3c1d
Autor:
Trung N. Tran, MD, PhD, Heath Heatley, PhD, Jennifer Rowell, MSc, Jeffrey Shi Kai Chan, MBChB, MPH, Arnaud Bourdin, MD, PhD, Jatin Chapaneri, MD, Benjamin Emmanuel, PhD, Danny Gibson, MSc, David J. Jackson, MRCP, Andrew N. Menzies-Gow, FRCPi, Ruth Murray, PhD, Derek Skinner, MSc, David B. Price, FRCGP
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 3, Iss 2, Pp 100225- (2024)
Background: Increasing frequency of intermittent oral corticosteroid (OCS) prescription and cumulative OCS exposure increase the risk of OCS-related adverse outcomes. Objective: We sought to describe the evolution and trajectory of intermittent OCS p
Externí odkaz:
https://doaj.org/article/a6b326d0480546b0b054b4170e457828
Autor:
Celeste M. Porsbjerg, John Townend, Celine Bergeron, George C. Christoff, Gregory P. Katsoulotos, Désirée Larenas-Linnemann, Trung N. Tran, Riyad Al-Lehebi, Sinthia Z. Bosnic-Anticevich, John Busby, Mark Hew, Konstantinos Kostikas, Nikolaos G. Papadopoulos, Paul E. Pfeffer, Todor A. Popov, Chin Kook Rhee, Mohsen Sadatsafavi, Ming-Ju Tsai, Charlotte Suppli Ulrik, Mona Al-Ahmad, Alan Altraja, Aaron Beastall, Lakmini Bulathsinhala, Victoria Carter, Borja G. Cosio, Kirsty Fletton, Susanne Hansen, Liam G. Heaney, Richard B. Hubbard, Piotr Kuna, Ruth B. Murray, Tatsuya Nagano, Laura Pini, Diana Jimena Cano Rosales, Florence Schleich, Michael E. Wechsler, Rita Amaral, Arnaud Bourdin, Guy G. Brusselle, Wenjia Chen, Li Ping Chung, Eve Denton, Joao A. Fonseca, Flavia Hoyte, David J. Jackson, Rohit Katial, Bruce J. Kirenga, Mariko Siyue Koh, Agnieszka Ławkiedraj, Lauri Lehtimäki, Mei Fong Liew, Bassam Mahboub, Neil Martin, Andrew N. Menzies-Gow, Pee Hwee Pang, Andriana I. Papaioannou, Pujan H. Patel, Luis Perez-De-Llano, Matthew J. Peters, Luisa Ricciardi, Bellanid Rodríguez-Cáceres, Ivan Solarte, Tunn Ren Tay, Carlos A. Torres-Duque, Eileen Wang, Martina Zappa, John Abisheganaden, Karin Dahl Assing, Richard W. Costello, Peter G. Gibson, Enrico Heffler, Jorge Máspero, Stefania Nicola, Diahn-Warng Perng (Steve), Francesca Puggioni, Sundeep Salvi, Chau-Chyun Sheu, Concetta Sirena, Camille Taillé, Tze Lee Tan, Leif Bjermer, Giorgio Walter Canonica, Takashi Iwanaga, Libardo Jiménez-Maldonado, Christian Taube, Luisa Brussino, David B. Price
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundTo date, studies investigating the association between pre-biologic biomarker levels and post-biologic outcomes have been limited to single biomarkers and assessment of biologic efficacy from structured clinical trials.AimTo elucidate the a
Externí odkaz:
https://doaj.org/article/785ec080909546459be89268c120b71f
Publikováno v:
EBioMedicine, Vol 102, Iss , Pp 105059- (2024)
Externí odkaz:
https://doaj.org/article/fa1ada148c994fc19b80a138905e42af
Autor:
Athénaïs Boucly, Sabina Solinas, Antoine Beurnier, Xavier Jaïs, Sophia Keddache, Mélanie Eyries, Andrei Seferian, Mitja Jevnikar, Anne Roche, Sophie Bulifon, Arnaud Bourdin, Ari Chaouat, Vincent Cottin, Laurent Bertoletti, Laurent Savale, Marc Humbert, Olivier Sitbon, David Montani
Publikováno v:
ERJ Open Research, Vol 10, Iss 1 (2024)
Introduction Pulmonary veno-occlusive disease (PVOD) is a rare and severe subtype of pulmonary arterial hypertension (PAH). Although European Society of Cardiology/European Respiratory Society (ESC/ERS) guidelines advise assessing PAH severity at bas
Externí odkaz:
https://doaj.org/article/a3a5886fc8314a5fa2fce871c4885790
Autor:
Laurent Guilleminault, Claire Camus, Chantal Raherison-Semjen, Audrey Capdepon, Arnaud Bourdin, Philippe Bonniaud, Stéphanie Fry, Gilles Devouassoux, François-Xavier Blanc, Christophe Pison, Clairelyne Dupin, Naji Khayath, Joelle Courdeau, Judith Valcke-Brossollet, Cécilia Nocent-Ejnaini, Fabien Rolland, Carmen Lamandi, Alain Proust, Anaig Ozier, Laurent Portel, Wanda Gaspard, Pauline Roux-Claude, Antoine Beurnier, Stéphanie Martinez, Jean-Marc Dot, Florence Hennegrave, Guillaume Vignal, Etienne Auvray, Nicolas Paleiron, Nicolas Just, Jean Miltgen, Maud Russier, Cécile Olivier, Camille Taillé, Alain Didier
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 17 (2023)
Background: Biological therapies have revolutionized the treatment of severe asthma with type 2 inflammation. Although such treatments are very effective in reducing exacerbation and the dose of oral steroids, little is known about the persistence of
Externí odkaz:
https://doaj.org/article/c75b2e5e63204908b0c7dc6bd3893d10
Autor:
John Haughney, Trung N. Tran, Heath Heatley, Arnaud Bourdin, Andrew Menzies-Gow, David J. Jackson, Ekaterina Maslova, Jatin Chapaneri, Derek Skinner, Victoria Carter, Jeffrey Shi Kai Chan, David Price
Publikováno v:
npj Primary Care Respiratory Medicine, Vol 33, Iss 1, Pp 1-5 (2023)
Abstract An algorithm to describe patterns of intermittent oral corticosteroid use in the UK (n = 476,167) found that one-third of patients receiving intermittent oral corticosteroids for asthma only had short gaps (
Externí odkaz:
https://doaj.org/article/671d13db0b624043963fa8035203f4ad